Cargando…

Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case

BACKGROUND: The analysis of statutory health insurance (SHI) data is a little-used approach for understanding treatment and care as well as resource use of lung cancer (LC) patients in Germany. The aims of this observational, retrospective, longitudinal analysis of structured data were to analyze th...

Descripción completa

Detalles Bibliográficos
Autores principales: Neugebauer, Sina, Griesinger, Frank, Dippel, Sabine, Heidenreich, Stephanie, Gruber, Nina, Chruscz, Detlef, Lempfert, Sebastian, Kaskel, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241287/
https://www.ncbi.nlm.nih.gov/pubmed/35765059
http://dx.doi.org/10.1186/s12913-022-07982-8
_version_ 1784737771137531904
author Neugebauer, Sina
Griesinger, Frank
Dippel, Sabine
Heidenreich, Stephanie
Gruber, Nina
Chruscz, Detlef
Lempfert, Sebastian
Kaskel, Peter
author_facet Neugebauer, Sina
Griesinger, Frank
Dippel, Sabine
Heidenreich, Stephanie
Gruber, Nina
Chruscz, Detlef
Lempfert, Sebastian
Kaskel, Peter
author_sort Neugebauer, Sina
collection PubMed
description BACKGROUND: The analysis of statutory health insurance (SHI) data is a little-used approach for understanding treatment and care as well as resource use of lung cancer (LC) patients in Germany. The aims of this observational, retrospective, longitudinal analysis of structured data were to analyze the healthcare situation of LC patients in Germany based on routine data from SHI funds, to develop an algorithm that sheds light on LC types (non-small cell / NSCLC vs. small cell / SCLC), and to gain new knowledge to improve needs-based care. METHODS: Anonymized billing data of approximately four million people with SHI were analyzed regarding ICD-10 (German modification), documented medical interventions based on the outpatient SHI Uniform Assessment Standard Tariff (EBM) or the inpatient Operations and Procedure Code (OPS), and the dispensing of prescription drugs to outpatients (ATC classification). The study included patients who were members of 64 SHI funds between Jan-1st, 2015 and Dec-31st, 2016 and who received the initial diagnosis of LC in 2015 and 2016. RESULTS: The analysis shows that neither the cancer type nor the cancer stage can be unambiguously described by the ICD-10 coding. Furthermore, an assignment based on the prescribed medication provides only limited information: many of the drugs are either approved for both LC types or are used off-label, making it difficult to assign them to a specific LC type. Overall, 25% of the LC patients were unambiguously identifiable as NSCLC vs SCLC based on the ICD-10 code, the drug therapy, and the billing data. CONCLUSIONS: The current coding system appears to be of limited suitability for drawing conclusions about LC and therefore the SHI patient population. This makes it difficult to analyze the healthcare data with the aim of gathering new knowledge to improve needs-based care. The approach chosen for this study did not allow for development of a LC differentiation algorithm based on the available healthcare data. However, a better overview of patient specific needs could make it possible to modify the range of services provided by the SHI funds. From this perspective, it makes sense, in a first step, to refine the ICD-10 system to facilitate NSCLC vs. SCLC classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-07982-8.
format Online
Article
Text
id pubmed-9241287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92412872022-06-30 Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case Neugebauer, Sina Griesinger, Frank Dippel, Sabine Heidenreich, Stephanie Gruber, Nina Chruscz, Detlef Lempfert, Sebastian Kaskel, Peter BMC Health Serv Res Research BACKGROUND: The analysis of statutory health insurance (SHI) data is a little-used approach for understanding treatment and care as well as resource use of lung cancer (LC) patients in Germany. The aims of this observational, retrospective, longitudinal analysis of structured data were to analyze the healthcare situation of LC patients in Germany based on routine data from SHI funds, to develop an algorithm that sheds light on LC types (non-small cell / NSCLC vs. small cell / SCLC), and to gain new knowledge to improve needs-based care. METHODS: Anonymized billing data of approximately four million people with SHI were analyzed regarding ICD-10 (German modification), documented medical interventions based on the outpatient SHI Uniform Assessment Standard Tariff (EBM) or the inpatient Operations and Procedure Code (OPS), and the dispensing of prescription drugs to outpatients (ATC classification). The study included patients who were members of 64 SHI funds between Jan-1st, 2015 and Dec-31st, 2016 and who received the initial diagnosis of LC in 2015 and 2016. RESULTS: The analysis shows that neither the cancer type nor the cancer stage can be unambiguously described by the ICD-10 coding. Furthermore, an assignment based on the prescribed medication provides only limited information: many of the drugs are either approved for both LC types or are used off-label, making it difficult to assign them to a specific LC type. Overall, 25% of the LC patients were unambiguously identifiable as NSCLC vs SCLC based on the ICD-10 code, the drug therapy, and the billing data. CONCLUSIONS: The current coding system appears to be of limited suitability for drawing conclusions about LC and therefore the SHI patient population. This makes it difficult to analyze the healthcare data with the aim of gathering new knowledge to improve needs-based care. The approach chosen for this study did not allow for development of a LC differentiation algorithm based on the available healthcare data. However, a better overview of patient specific needs could make it possible to modify the range of services provided by the SHI funds. From this perspective, it makes sense, in a first step, to refine the ICD-10 system to facilitate NSCLC vs. SCLC classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-07982-8. BioMed Central 2022-06-28 /pmc/articles/PMC9241287/ /pubmed/35765059 http://dx.doi.org/10.1186/s12913-022-07982-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Neugebauer, Sina
Griesinger, Frank
Dippel, Sabine
Heidenreich, Stephanie
Gruber, Nina
Chruscz, Detlef
Lempfert, Sebastian
Kaskel, Peter
Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
title Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
title_full Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
title_fullStr Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
title_full_unstemmed Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
title_short Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
title_sort use of algorithms for identifying patients in a german claims database: learnings from a lung cancer case
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241287/
https://www.ncbi.nlm.nih.gov/pubmed/35765059
http://dx.doi.org/10.1186/s12913-022-07982-8
work_keys_str_mv AT neugebauersina useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT griesingerfrank useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT dippelsabine useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT heidenreichstephanie useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT grubernina useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT chrusczdetlef useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT lempfertsebastian useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase
AT kaskelpeter useofalgorithmsforidentifyingpatientsinagermanclaimsdatabaselearningsfromalungcancercase